Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipoxygenases (LOX) and cyclooxygenases (COX) are two distinct families of enzymes that catalyze the oxygenation of polyunsaturated fatty acids, such as arachidonic acid, leading to the production of various bioactive lipid mediators known as eicosanoids. These enzymes play crucial roles in inflammation, cancer progression, and other physiological and pathological processes. They are major drug targets for inflammatory diseases and cancer.
Inhibition of eicosanoid synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipoxygenase-Cyclooxygenase (LOX-COX).